# ChatTogoVar

### Evaluation of rs121918719 for Genome Editing (CRISPR)

The variant **rs121918719** is located in the **TGM1 gene** (transglutaminase 1) and has biological and clinical significance, making it a potential target for precise genome editing. Here's an analysis of the information specifically related to its suitability as a CRISPR target:

---

#### 1. **Variant Information**
   - **RS Number**: [rs121918719](https://identifiers.org/dbsnp/rs121918719)
   - **HGVS**:
     - Genomic: `chr14:g.24261775C>T`
     - Coding Transcript: `NM_000359.3:c.428G>A`
     - Protein Change: `NP_000350.1:p.Arg143His`
   - **Gene Name**: **TGM1**
   - **Transcript**: **ENST00000206765**, **NM_000359.3**

   The variant results in a missense mutation, **p.Arg143His**, which alters the amino acid arginine to histidine. This pathogenic variant is implicated in **autosomal recessive congenital ichthyosis 1 (ARCI1)**, a severe disorder of skin barrier function.

---

#### 2. **Association with Diseases**
   - **Pathogenicity**: Assessed as **Pathogenic (P)** or **Likely Pathogenic (LP)** in ClinVar.
   - **Disease Link**: Associated with **autosomal recessive congenital ichthyosis 1 (ARCI1)** and **abnormality of the skin**.
   - Functional predictions:
     - **SIFT**: 0.0 (Damaging)
     - **PolyPhen-2**: 0.995 (Probably Damaging)
     - **AlphaMissense**: 0.8876 (Likely Pathogenic)

   Editing this variant could have therapeutic applications in correcting the genetic mutation causing **ARCI1**.

---

#### 3. **Population Frequency**
   - **Japanese (ToMMo)**: Allele frequency: `0.000018` (2/108604 alleles)
   - **gnomAD Exomes**: Allele frequency: `0.000016` (23/1461886 alleles)
   - **gnomAD Genomes**: Allele frequency: `0.0000066` (1/152044 alleles)

   These low allele frequencies indicate the variant is rare globally and even in specific populations, which is consistent with its role in a rare recessive condition.

---

#### 4. **CRISPR Feasibility**
   **Genome Editing Considerations**:
   - **Site Accessibility**: Based on its precise location (chr14:g.24261775), guide RNA can be designed for CRISPR targeting. Its functional status in the coding region makes it a good target for repair.
   - **Potential Applications**:
     - **Therapeutic gene correction**: Correcting the c.428G>A mutation back to the wild-type allele (C:G) may alleviate the clinical effects of ichthyosis in affected individuals.
     - **Model Development**: Generating cellular or animal models with this variant could help in studying ARCI1 pathogenesis and developing treatments.

   **Potential Challenges**:
   - **Risk of Off-Target Effects**: Proper guide RNA design and rigorous testing must minimize unwanted edits in regions with similar sequences.
   - **Efficiency of Repair**: Homology-directed repair (HDR) may have lower efficiency, especially in non-dividing cells, compared to non-homologous end joining (NHEJ).
   - **Functional Validation**: The correction of the mutation must demonstrate restoration of **TGM1 function** in relevant tissue (e.g., skin keratinocytes).

---

#### 5. **TogoVar References**
   - [TogoVar Information: 14:24261775](https://jmorp.megabank.tohoku.ac.jp/search?query=14%3A24261775)
   - [ClinVar: VCV000012481](https://www.ncbi.nlm.nih.gov/clinvar/variation/12481)
   - [gnomAD: 14-24261775-C-T](https://gnomad.broadinstitute.org/variant/14-24261775-C-T?dataset=gnomad_r4)

---

#### Conclusion:
**Yes**, rs121918719 can be considered a valid target for genome editing using CRISPR, particularly for therapeutic intervention in individuals with ARCI1 or for research purposes. Careful CRISPR design and validation, along with preclinical studies, would be essential for successful application.

For further inquiries, please consult resources such as ClinVar or gnomAD for clinical or functional data.